LANCASTER COUNTY, Pa. —

Terry Becker, a retired fifth-grade teacher from Lancaster County, Pennsylvania, says he feels he's experiencing positive effects from one of two new FDA-approved drugs designed to slow the progression of certain types of Alzheimer's and dementia.

Terry's wife, Pam, says she noticed his memory slipping months ago, leading to a neurological assessment that diagnosed him with mild cognitive impairment, or MCI.

New Alzheimer's drugs

While the causes of MCI, Alzheimer's and dementia remain unknown, doctors are concentrating on the buildup of amyloid protein in the brain. Two new drugs, Leqembi and Kisunla, have been introduced to help combat this issue.

"When these drugs became available, we were very excited. Now we have something that could potentially stop this

See Full Page